NSCs are permissive to oncolytic Myxoma virus and provide a delivery method for targeted ovarian cancer therapy is a research paper published in Oncotarget (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA197359
NCI NIH HHS
Grant: P30 CA033572
National Institutes of Health
Grant: 1R43CA086768-01
HUMAN NEURAL STEM CELLS TARGET GENE THERAPY-BRAIN TUMORS
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
National Institutes of Health
Grant: 5R01CA197359-02
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
FWCI
0.96
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals